Artelo (ARTL) Director Tamara Favorito Receives 136-Share Award

What Happened
Tamara A. Favorito, a director of Artelo Biosciences, was granted 136 derivative shares (transaction code A) on July 17, 2026. The award shows an acquisition price of $0.00 (no cash paid). The grant is subject to vesting conditions and does not represent an immediate open-market purchase or sale.

Key Details

• Transaction date: 2026-07-17; Form 4 filed 2026-07-21 (filed within the SEC’s two-business-day window).
• Grant: 136 shares; reported price: $0.00 (derivative award).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: The 136 shares vest 100% on the earlier of (i) one year after the vesting commencement date (Vesting Commencement Date = July 17, 2026) or (ii) the day before the issuer’s next annual meeting, provided Favorito remains a service provider through each applicable vesting date.
• Transaction type: Award/grant of derivative securities (code A), not a purchase (P) or sale (S).

Context
This was a time- or service-based award (likely restricted shares or stock units) rather than an exercised option or immediate sale. Such grants are routine compensation for directors and do not, by themselves, indicate buying or selling sentiment; vesting depends on continued service.